John R James1. 1. Molecular Immunity Unit, Department of Medicine, University of Cambridge, Medical Research Council Laboratory of Molecular Biology, Cambridge CB2 OQH, UK. Email: jj400@cam.ac.uk.
Abstract
The T cell antigen receptor (TCR) recognizes peptides from pathogenic proteins bound in the major histocompatibility complex (MHC). To convert this binding event into downstream signaling, the TCR complex contains immunoreceptor tyrosine-based activation motifs (ITAMs) that act as docking sites for the cytoplasmic tyrosine kinase ZAP-70. Unique among antigen receptors, the TCR complex uses 10 ITAMs to transduce peptide-MHC binding to the cell interior. Using synthetic, drug-inducible receptor-ligand pairs, it was found that greater ITAM multiplicity primarily enhanced the efficiency with which ligand binding was converted into an intracellular signal. This manifested as an increase in the fraction of cells that became activated in response to antigen, and a more synchronous initiation of TCR-proximal signaling, rather than direct amplification of the intracellular signals. Exploiting these findings, the potency and selectivity of chimeric antigen receptors targeted against cancer were substantially enhanced by modulating the number of encoded ITAMs.
The T cell antigen receptor (TCR) recognizes peptides from pathogenic proteins bound in the major histocompatibility complex (MHC). To convert this binding event into downstream signaling, the TCR complex contains immunoreceptor tyrosine-based activation motifs (ITAMs) that act as docking sites for the cytoplasmic tyrosine kinase ZAP-70. Unique among antigen receptors, the TCR complex uses 10 ITAMs to transduce peptide-MHC binding to the cell interior. Using synthetic, drug-inducible receptor-ligand pairs, it was found that greater ITAM multiplicity primarily enhanced the efficiency with which ligand binding was converted into an intracellular signal. This manifested as an increase in the fraction of cells that became activated in response to antigen, and a more synchronous initiation of TCR-proximal signaling, rather than direct amplification of the intracellular signals. Exploiting these findings, the potency and selectivity of chimeric antigen receptors targeted against cancer were substantially enhanced by modulating the number of encoded ITAMs.
Authors: Haopeng Wang; Theresa A Kadlecek; Byron B Au-Yeung; Hanna E Sjölin Goodfellow; Lih-Yun Hsu; Tanya S Freedman; Arthur Weiss Journal: Cold Spring Harb Perspect Biol Date: 2010-05 Impact factor: 10.005
Authors: Lakshmi Balagopalan; Nathan P Coussens; Eilon Sherman; Lawrence E Samelson; Connie L Sommers Journal: Cold Spring Harb Perspect Biol Date: 2010-07-07 Impact factor: 10.005
Authors: Guoping Fu; Yuhong Chen; Mei Yu; Andy Podd; James Schuman; Yinghong He; Lie Di; Maryam Yassai; Dipica Haribhai; Paula E North; Jack Gorski; Calvin B Williams; Demin Wang; Renren Wen Journal: J Exp Med Date: 2010-02-01 Impact factor: 14.307
Authors: J S Bridgeman; K Ladell; V E Sheard; K Miners; R E Hawkins; D A Price; D E Gilham Journal: Clin Exp Immunol Date: 2014-02 Impact factor: 4.330
Authors: Himadri Mukhopadhyay; Shaun-Paul Cordoba; Philip K Maini; P Anton van der Merwe; Omer Dushek Journal: PLoS Comput Biol Date: 2013-03-28 Impact factor: 4.475
Authors: Shio Kobayashi; Martin A Thelin; Heather L Parrish; Neha R Deshpande; Mark S Lee; Alborz Karimzadeh; Monika A Niewczas; Thomas Serwold; Michael S Kuhns Journal: Proc Natl Acad Sci U S A Date: 2020-11-02 Impact factor: 11.205
Authors: Lam-Kiu Fong; Matthew J Chalkley; Sophia K Tan; Michael Grabe; William F DeGrado Journal: Proc Natl Acad Sci U S A Date: 2021-06-29 Impact factor: 11.205